Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders

Methods in Molecular Biology

Volumn 1109, Issue , 2014, Pages 187-207

  Elmaagacli, Ahmet H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

FLT3 length mutations; Fusion transcripts; MRD; Myeloid disorders; Real time RT PCR; Transplant; WT1

Indexed keywords

BCR ABL PROTEIN; CD135 ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOPHOSMIN; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DENATURATION; DNA ISOLATION; DNA SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOUSEKEEPING GENE; HUMAN; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TEMPERATURE;

CHROMOSOME ABERRATIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MUTATION; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION;

EID: 84934438001     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-9437-9_11     Document Type: Article

References (33)

1. Elmaagacli AH, Becks HW, Beelen DW et al (1995) Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non T-cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia. Bone Marrow Transplant 16:823-829
2. Mackinnon S, Barnett L, Heller G, O'Reilly RJ (1994) Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 83:3409-3416
3. Kolb H, Mittermuller J, Clemm C et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465
4. Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW (1999) The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared to bone marrow. Blood 94:384-389
5. Kiyoi H, Naoe T, Yokota S et al (1997) Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia 11:1447-1452
6. Gorello P, Cazzaniga G, Alberti F et al (2006) Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations. Leukemia 20:1103-1108
7. Marcucci G, Haferlach T, Dohner H (2011) Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol 29:475-486
8. Kumar CC (2011) Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer 2:95-107
9. Sanders MA, Valk PJM (2013) The evolving molecular genetic landscape in acute myeloid leukaemia. Curr Opin Hematol 20:79-85
10. Elmaagacli AH, Freis A, Hahn M et al (2001) Estimate the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new realtime polymerase chain reaction method. Br J Haematol 113:1072-1075
11. Reading CL, Estey EH, Huh YO et al (1996) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81:3083-3090
12. Macedo A, San Miguel JF, Vidriales MB et al (1996) Phenotypic changes in acute myeloid leukaemia: implications on the detection of minimal residual disease. J Clin Pathol 49:15-18
13. Bernell P, Arvidsson I, Jacobsson B, Hast R (1996) Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia. Br J Haematol 95:666-672
14. Weisser M, Haferlach T, Schoch C et al (2003) The use of housekeeping genes for real-time PCR based quantification of fusion gene transcripts in AML. Leukemia 17:2474-2486
15. Holland PM, Abramson RD, Watson R, Gelfand DH (1991) Detection of specific polymerase chain reaction product utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88:7276-7280
16. Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237-238
17. Burmeister T, Maurer J, Aivado M et al (2000) Quality assurance in RT-PCR-based BCR/ ABL diagnostics-results of an interlaboratory test and a standardization approach. Leukemia 14:1850-1856
18. Schnittger S, Weiser M, Schoch C et al (2003) New score predicting for prognosis in PMLRARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 102:2746-2755
19. Krauter J, Wattjes MP, Nagel S et al (1999) Real-time RT-PCR for the detection and quantification of AML1/MTG fusion transcripts in t(8;21)-positive AML patients. Br J Haematol 107:80-85
20. Elmaagacli AH, Beelen DW, Kroll M et al (1997) Detection of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantation. Blood 90:3230-3231
21. Guerrasio A, Pilatrino C, De Micheli D et al (2002) Assessment of minimal residual disease (MRD) in CHFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia 16:1176-1181
22. Krauter J, Hoellge W, Wattjes MP et al (2001) Detection and quantification of CBFB/ MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukaemia by real-time RT-PCR. Genes Chromosomes Cancer 30:342-348
23. Marcucci G, Caliguri MA, Dohner H et al (2001) Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) AML. Leukemia 15:1072-1080
24. Buonamici S, Ottaviani E, Testoni N et al (2002) Real-time quantification of minimal residual disease in inv (16)-positive acute myeloid leukaemia may indicate risk for clinical relapse and may identify patients in a curable state. Blood 99:443-449
25. Elmaagacli AH, Beelen DW, Kroll M, Trzensky S, Stein C, Schaefer UW (1998) Detection of CBFB/MYH11 fusion transcripts in patients with inv(16) AML after allogeneic bone marrow or peripheral blood progenitor cell transplantation. Bone Marrow Transplant 21: 159-166
26. Gallagher RE, Yeap BY, Bi W et al (2003) Quantitative real-time RT-PCR analysis of PML-RARA alpha mRNA in acute promyelocytic leukaemia: Assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 101:2521-2528
27. Ogawa H, Tamaki H, Ikegame K et al (2003) The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukaemia. Blood 101:1698-1704
28. Cilloni D, Gottardi E, Fava M et al (2003) Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection. Blood 102:773-774
29. Elmaagacli AH, Beelen DW, Trenschel R, Schaefer UW (2000) The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation. Bone Marrow Transplant 25:91-96
30. Vaughn CP, Elenitoba-Johnson KSJ (2004) High-resolution melting analysis for detection of internal tandem duplications. J Mol Diagn 6:211-216
31. Schnittger S, Schoch C, Dugas M et al (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100:59-66
32. Yokota S, Kiyoi H, Nakao M et al (1997) Internal tandem duplications of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 11:1605-1609
33. Repp R, Borkhardt A, Haupt E et al (1995) Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescent-based automatic DNA-fragment analysis. Leukemia 9:210-216